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Abstract
Background: Databases are frequently used for pharmacoepidemiological research. However,
most of these databases consist either of prescri b i n g ,  d i s p e n s i n g  o r  a d ministrative data and
therefore lack insight in the interaction between the several health professionals around the
patient.
Methods: To determine the success rate of linking records from the dispensing database of the
Foundation for Pharmaceutical Statistics to the prescribing database of the second Dutch national
survey of general practice, conducted by NIVEL (Netherlands Institute for Health Services
Research), a deterministic record linkage approach was used with patient and prescription
characteristics as matching variables between the two databases.
Results:  The catchment area included 123 community pharmacies, 90 GP practices and
approximately 170,000 unique patients. Overall 110,102 (64.8%) unique patients were linked using
the matching variables patient's gender, year of birth, the 4-digit part of the postal code, date of
dispensing/prescribing and ATC-code. The final database contains of the 110,102 both prescribing
data from 83 GP practices and dispensing data of 112 community pharmacies.
Conclusion: This study shows that linkage of dispensing to prescribing data is feasible with a
combination of patient characteristics, such as gender, year of birth and postal code, and
prescription characteristics like prescription date and ATC-code. We obtained a linkage
proportion of 64.8% resulting in complete prescribing and dispensing history of 110,102 patients.
This offers an opportunity to gain insight in the mechanisms and factors influencing drug utilisation
in general practice.
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Background
To enhance the quality and efficiency of observational
research in daily clinical practice, linkage of different data-
bases is often desirable to gain more insight in the under-
lying mechanisms by which medicines are utilised in large
populations. Linkage of dispensing data from community
pharmacies to hospital admission data, for example, has
proven to be beneficial in detecting serious drug-induced
side-effects [1,2]. Although important findings have been
published, most of the databases used so far consist of
either prescribing data of general practitioners (GPs),
pharmacy records or administrative data from health
insurance companies [3,4]. The origin of these databases
defines the vantage point of the researcher and may there-
fore limit the usefulness of the data. For example, pre-
scribing data of GPs alone are not sufficient to compile a
clear overview of all drugs prescribed in general practice.
Prescriptions of hospital specialists are usually not
archived in GP prescribing databases and, unless repeated
by GPs, result in blind spots. Furthermore, due to inter-
ventions of community pharmacists to optimise pharma-
cotherapy or prevent possible side effects the dispensed
drug may not be the same as the drug prescribed by the
GP. This can also cause differences in prescribing and dis-
pensing databases [5].
In the Netherlands, several organisations are involved in
routine collection of medical records, such as prescribing
data of GPs [6,7] and dispensing data from community
pharmacies [8]. In 2000, NIVEL (Netherlands Institute for
Health Services Research) launched the second Dutch
national survey of general practice (DNSGP-2) to obtain
up-to-date and national representative data on the Dutch
general practice. The rationale and design of the DNSGP-
2 is discussed in detail elsewhere [9,10]. The DNSGP-2
resulted among other things in a dataset comprising over
two million prescriptions, prescribed by 101 GP practices
to 262,817 patients in the period October 2000 to January
2002. For each prescription information was available on
the prescription date, quantity prescribed, duration of use,
product code, ATC code, [11] and ICPC coded diagnose
[12]. GPs were asked to fill in a thorough questionnaire
about several topics, including their attitude to new drug
prescribing, the number of visits by drug company repre-
sentatives, the use of information sources on pharmaco-
therapy, and use of guidelines. Patients provided
information about ten socio-demographic characteristics,
including among other things age, gender, type of insur-
ance, self-perceived health and highest level of education.
The DNSGP-2 provided a unique opportunity to link
detailed information on both GPs and patients to dis-
pensing data from community pharmacies to obtain a
complete overview of the Dutch primary care.
Pharmacy dispensing data are collected in the Nether-
lands by the Foundation for Pharmaceutical Statistics
(SFK) [8]. Since 1990, the SFK has been collecting dis-
pensing data from a growing number of community phar-
macies in the Netherlands. In 2004, the catchment area of
the SFK consisted of 1,540 community pharmacies, which
represent 90% of the total number of Dutch pharmacies.
The panel of pharmacies serves 13.5 million people and
together dispense medicines, medical aid or bandages
about 130 million times per year [8]. Both the DNSGP-2
and the SFK database display important -and partly over-
lapping- parts of Dutch primary care.
As in most other healthcare systems, information is
increasingly stored in electronic form and made available
for scientific research. Combining the different databases
makes it possible to eliminate the shortcomings of indi-
vidual databases and could result in opportunities greater
than those presently thought of. Primary non-compli-
ance, generic substitution, and interventions by pharma-
cists are just a few topics that could be addressed [13-15].
Therefore, the objective of this study was to determine the
success rate of linkage of records of patients from the SFK
dispensing database to the prescribing database of the
DNSGP-2. Combining the information from both data
sources offers an opportunity to gain more insight into the
factors influencing drug exposure in patients.
Methods
Data collection
All GPs who participated in the DNSGP-2 listed the phar-
macies where most of their patients filled their prescrip-
tions. All pharmacists from the identified pharmacies
were invited by letter to participate and followed-up with
a telephone call 1–2 weeks later. To maximise the likeli-
hood of tracing all patients we also contacted the pharma-
cies in the adjoining postal code areas. From the
pharmacies that agreed to participate, dispensing data
were collected from the SFK. The collected dispensing data
covered the period January 1999 until December 2003,
whereas the prescribing data were mainly from the year
2001. Since not all patient of the same GP visit the same
pharmacy and not all pharmacies agreed to participate, we
estimated the total number of eligible patients to be
approximately 170,000. The estimation was based on the
GP practice size, number of participating pharmacies and
calculated by using estimates made by pharmacists of the
percentage of a particular GP practice population that fills
prescriptions at their pharmacy.
Matching procedure
We used a deterministic linkage method to match patient
records from both data sources by using patient identifiers
year of birth, gender and 4-digit postal code. The combi-
nation of these three characteristics, however, is notBMC Medical Informatics and Decision Making 2006, 6:18 http://www.biomedcentral.com/1472-6947/6/18
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unique enough to identify patients within a GP practice of
approximately 2,300 patients, let alone in a Dutch phar-
macy listing on average 9,000 patients [8]. Therefore, we
used prescriptions characteristics as identifiers, namely
the Anatomical Therapeutic Classification code (ATC-
code) [16] and prescribing date. The identifiers are listed
in Figure 1. The records from the prescription database of
the DNSGP-2 were defined as enquiry records (i.e. those
from which is searched), whereas the pharmacy records
were defined as the file records (i.e. those that have to be
retrieved). For each enquiry record, all file records are
compared with respect to characteristics that are present in
or logically related to both types of records.
The matching procedure consisted of several subsequent
steps. Firstly, patients were blocked on a combination of
gender, year of birth and the 4-digit numbers of their
postal code. Subsequently, the prescriptions of the
patients recorded in both databases were compared
within the blocks. Prescriptions were matched on date,
ATC-code and specificity of ATC-code. Up to ten prescrip-
tions per patient were used for matching. A successful
match of patients' records was defined as a positive match
on gender, year of birth, postal code and a minimum of
50% of enquiry prescriptions found.
By using prescriptions as patient identifiers, several
aspects have to be taken into account. Firstly, medication
is not always filled on the same day it is prescribed. Cer-
tainly nowadays, patients frequently request a refill pre-
scription by phone, often pick it up at the pharmacy the
next day [17]. This results in a lag period of a few days
between prescribing and dispensing. We defined a lag-
time of four days as realistic. This means that patients'
records could still be linked when there was a four days
difference between prescribing and dispensing date.
Secondly, the ATC-code of the prescribed drug does not
have to be identical in the seven characters to the dis-
pensed drug. Differences in ATC-code may be caused by
interventions of community pharmacists to optimise
pharmacotherapy or prevent possible adverse drug reac-
tions [14,18]. To allow interventions by the pharmacists,
matching occurred in two stages. Patients were first
matched using the complete ATC-code. When successfully
linked, the patients' records were deleted from the enquiry
and file database. The remaining patient records were
matched using the first three characters of the ATC-code.
Thirdly, some drugs are prescribed more than others are.
To benefit from this frequency of prescribing we catego-
rised drugs in the enquiry database in three groups,
namely drugs that were prescribed less than 5,000 times,
between 5,000 and 10,000 times and more than 10,0000
times. Patient records were first matched by using drugs
that were prescribed the least, followed by more common
drugs. To safeguard patient privacy the study was con-
ducted under strict privacy regulation of the DNSGP-2 [9].
Results
Among the 101 GP practices in the DNSGP-2, eleven were
dispensing practices and were excluded. The analysis was
based on 233,303 patients who received 1,841,271 pre-
scriptions and were listed in 90 GP practices. Of the 203
community pharmacies approached, 123 (60.6%) phar-
macies dispensed medication to patients of the particular
GP and agreed to participate in the study. Of the 80 phar-
macies that decided not to participate, 71 pharmacist
responded never to dispense medication to patients of the
DNSGP-2 GPs and nine pharmacies refused to participate
in our study. This resulted in 89 GP practices of which
both prescribing and dispensing data were available for
matching. Taking into account the number of patients per
GP practice, coverage of GP practices by pharmacies and
registration period of both databases, we estimated that
approximately 170,000 patients could in theory be traced
in the pharmacy records. Figure 2 shows the sampling
procedure and subsequent outcome of the different steps
in the matching procedure.
Blocking patients on gender, year of birth, and postal
code, matching on full 7-character ATC-code resulted in
98,775 (58.1%) uniquely identified patients. The remain-
ing 71,225 patients not linked initially, were matched
using the 3-character ATC-code of the medicines pre-
scribed. Subsequently, 11,327 (6.7%) more patients were
matched. In total, medical records of 110,102 (64.8%)
patients from 83 GP practices were linked. Of these
patients, virtually complete prescribing and dispensing
histories are available. The prescribing data encompassed
for most of the patients the year 2001, whereas the dis-
pensing data covered the years 1999–2003.
Structure of the matching process Figure 1
Structure of the matching process.
Practice ID 
Patient ID 
Prescription date
ATC-code drug 
ICPC-diagnosis 
Prescribed units 
…..
…..
Medication file 
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Date of birth 
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….
….
Patient file 
Pharmacy ID 
Patient ID 
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Dispensed units 
….
….
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Insurance company 
….
Patient file 
DNSGP-2  SFK 
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Up to 10 ATC-code’s 
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Up to 10 ATC-code’s 
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The 110,102 linked patients filled 4,816,247 prescrip-
tions of both GPs and medical specialists during the
period 1999–2003, with an average of 43.7 (SD = 68.6)
prescriptions per patient. Of these patients, 58.0% were
female, 68.5% publicly insured and the mean age was
42.2 (SD = 21.8) years. Table 1 displays the characteristics
of the DNSGP-2, SFK and linked database. Although sta-
tistically significant due to the large number of patients,
there were no meaningful differences in patient character-
istics between the original DNSGP-2 and linked dataset,
except for the number of prescriptions per patient. The
proportion of women ranged from 57.4% in the DNSGP-
2 to 55.8% in the SFK data. The mean age of the patients
in the linked-database was 42.2 years and higher than the
mean age in the DNSGP-2 database (39.1 years) and the
SFK-database (38.4 years). The number of prescriptions
per patient in the SFK and linked database was higher
than in the DNSGP-2 due to the longer registration period
of the first two databases. After correction for the registra-
tion period, the number of prescriptions per patient per
month was 0.68 for the DNSGP-2, 0.63 for the SFK, and
0.91 for the linked database. The higher number of pre-
scriptions per patient in the linked database is the sum of
prescriptions of GPs and medical specialists, whereas the
DNSGP-2 only includes prescriptions of GPs. Further-
more, the higher number of prescriptions per patient is
also the result of the fact that only patients with prescrip-
tions could be linked. The characteristics of included GP
practices in the linked-database were also comparable to
the original sample of the DNSGP-2 with respect to type
of office, situated in deprived areas, and urbanisation
degree.
Discussion
The primary objective of this study was to determine the
success rate of linking dispensing data of community
pharmacies to prescribing data of general practitioners.
The completeness, quality and validity of patient charac-
teristics play a vital role in record linkage processes
[19,20]. If patient characteristics are not valid, or change
over time, this could negatively influence the matching.
Although gender and year of birth do not change over
time, they are still susceptible to registration errors [21].
However, we assumed that pharmacies and GPs register
the patient's date of birth accurately because it is often
used to retrieve the patient's history from the computer
systems. With respect to the completeness of the dispens-
ing data Herings defined five scenarios leading to incom-
pleteness, namely: (1) patients are not a member of the
catchment area, but incidentally fill a prescription in the
catchment area. (non-residents) (2) a patient number is
not uniquely assigned to one patient (non-unique assign-
ment) (3) a patient has more than one patient number in
the register (internal multi-unique assignment) (4) a
patient is registered in more than one pharmacy register
(external multi-unique assignment) (5) a patient living in
the catchment area fills a prescription outside the catch-
ment area (non-eligible) [4].
In the linkage method we used, linkage of non-residents
was unlikely. Although these patients filled a prescription
in the catchment area, they most likely did not receive a
prescription from a GP working in the catchment area.
Non-unique assignment is also very unlikely in Dutch
pharmacy and GP systems, as all systems do not allow
multiple assignment of a patient ID. Internal multiple
assignment of a patient to more than one number due to
entry errors of e.g. date of birth, gender or postal code, is
limited. Herings found in a sample of 2,000 patients that
1.4% of the patients were multiple coded in a pharmacy.
Finally, dispensing data can also be incomplete when
patients fill prescriptions outside the catchment area and
thereby become non-eligible. Herings et al. estimated the
completeness of drug dispensing histories in Dutch phar-
macies [4]. They found that more than 99% of all patients
had complete drug dispensing histories in cities where
pharmacists maintained one central patient register.
The factor that had the most negative influence on the
number of patients that could be matched was the differ-
ent registration periods of the pharmacies. Most of the GP
practices registered during twelve months (mean = 12, sd
= 1.6) over the period October 2000 till January 2002
while participating in the DNSGP-2, but not all pharma-
cies registered the same complete twelve months. Missing
months may be a main reason why patients' records could
not be linked. If a drug was prescribed during a period in
which no pharmacy data were available, this would lower
the probability of linking. Another important factor that
negatively influenced the matching process, are the phar-
macies that refused to participate in the study. It is often
Sampling procedure and outcome of matching Figure 2
Sampling procedure and outcome of matching.
123 pharmacies 
332,707 patients
89 GP practices 
+ Full ATC-code
+ 3 characters of 
ATC-code   +
90 GP practices 
233,303 patients
DNSGP-2  SFK  Eligible for matching
Blocking on: 
+
170,000 patients
89 GP practices 
1. Gender 
2.  Year of birth
3. Postal  code 
98,775 patients
11,327 patients
110,102 patients 
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difficult to trace patients back to a pharmacy, especially in
larger cities where patients of a GP may visit different
pharmacies. Part of the patients may go to one pharmacy,
while the other part goes to another pharmacy. This
means that if one pharmacy does not participate in the
study a part of the patient records cannot be linked. In a
sensitivity analysis we found that in isolated villages, the
percentage of linked patients was higher. However, the
lack of coverage of the GP practice by community phar-
macies resulted probably only in a reduction of the
number of patients that could be linked. We do not think
this negatively affected the completeness of dispensing
histories, because patients usually visit only one phar-
macy in the Netherlands.
The final linkage percentage of 64.8% is dependent on
several factors. One of the most important is the estima-
tion of the catchment population. We estimated the total
number of eligible patients to be 170,000, based on the
number of patients per GP practice, coverage of GP prac-
tices by pharmacies and the registration period of both
databases. The coverage of GP practices by pharmacies
was calculated by using estimates made by pharmacists of
the percentage of a particular GP practice population that
fills prescriptions at their pharmacy. For the GP practices
with less than 100% coverage, we performed a sensitivity
analysis on the estimations of pharmacists of the propor-
tion of patients from the GP practice filling prescriptions
in their pharmacy. Taking into account a 10% error range,
the catchment population ranged from 164,000 to
175,000 patients, meaning that the final linkage percent-
age ranged from 62.9% to 67.1%.
Furthermore, the final linkage percentage is also directly
influenced by the definition of a successful match. We
defined a successful match of patients' records when gen-
der, year of birth, postal code and a minimum of 50% of
enquiry prescriptions were positively matched. This cut-
off value is, of course, arbitrary and lowering this require-
ment positively influences the percentage of patients
being matched, but increases the number of false posi-
tives. Choosing 50% as a cut-off point, however, allows
matching of records of patients who only received two
prescriptions. Increasing the cut-off point to, for example
75%, excludes all patients who received up to four pre-
scriptions of which one or more were changed.
Limitations of the linking process lie mainly in the availa-
ble linkage keys. To ensure the privacy of patients, the SFK
only collects the year of birth and not the complete date
of birth. The combination of date of birth and gender is
almost unique in a population of 2,000 individuals. Since
the average Dutch GP practice consists of approximately
2,300 patients, the combination of gender and date of
birth would almost be sufficient to identify patients
within a GP practice. However, the specificity dramatically
decreases for the combination of year of birth and gender.
We decided not to use type of insurance as a matching var-
iable, because differentiating between private and public
insurance was difficult as some pharmacies register both
private and publicly insured patients of one insurance
company using a single code. Finally, we did not validate
our linkage procedure by contacting individual patients.
This is under the privacy statements of the DNSGP-2 and
the SFK prohibited. Several problems need further elabo-
ration when linkage of both systems will be done on a
continuous basis in the future.
Conclusion
This study shows that linkage of dispensing and prescrib-
ing data is feasible with a combination of patient charac-
teristics, such as gender, year of birth and postal code, and
prescription characteristics, like prescription date and
ATC-code. The final database contains both dispensing
and prescribing data of medical specialists and GPs com-
pleted with detailed information on not only the patients,
but also on community pharmacists and GPs. It offers an
opportunity to gain insight into the magnitude and direc-
tion of forces directing drug utilisation in general practice.
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Table 1: Characteristics the patients and GP practices in the enquiry, field and final database
Database DNSGP-2 SFK
Type Enquiry records File records Linked dataset
Time period Oct 2000 – Jun 2002 Jan 1999 – Dec 2003 Jan 1999 – Dec 2003
% Female 57.8% 55.8% 58.0% P < 0.02
% Publicly insured 67.5% -* 68.5% p < 0.00
Mean age (SD) 40.9 years (22.7) 38.4 years (22.7) 42.2 years (21.8) p < 0.00
Mean number of Rx/patient 
(SD)
7.9 (11.9) 28.9 (59.6) 43.7 (68.6) p < 0.00
Nr. of Rx/patients/month 0.68 0.63 0.91
Nr. of patients 233,303 332,707 110,102
Nr. of Rx 1,841,271 10,049,944 4,816,247
Pharmacies -** 123 112
GP practice N = 90*** N = 89 N = 83
Solo 49 (54.4%) 46 (53.5%) 43 (51.8%) p = 0.11
Duo 18 (20.0%) 17 (19.8%) 17 (20.5%)
Group 14 (15.6%) 14 (16.3%) 14 (16.9%)
Healthcare centre 9 (10.0%) 9 (10.5%) 9 (10.8%)
Deprived area 8 (8.9%) 8 (8.3%) 8 (9.6%)
Degree of urbanisation
Not urbanised 9 (10.0%) 9 (10.5%) 9 (12.0%) p = 0.21
Hardly urbanised 17 (18.9%) 16 (18.6%) 14 (16.9%)
Averaged urbanised 19 (21.1%) 19 (22.1%) 19 (22.9%)
Strongly urbanised 24 (26.7%) 22 (25.6%) 21 (24.1%)
Extremely urbanised 21 (23.3%) 20 (23.3%) 20 (24.1%)
We used chi-square to test for differences in % female, % publicly insured, practice type, and degree of urbanisation. T-test was used for mean age, 
and Mann-Whitney U-test for mean number of Rx/patient. Differences were assessed between DNSGP-2 versus linked dataset.
* Not used in the linkage process
** Not available in the DNSGP-2
*** Only non-dispensing GP practices included. In total 101 GP-practices collected prescribing data during the DNSGP-2